{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:31:04Z","timestamp":1785825064286,"version":"3.56.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.reuma.2014.09.003","type":"journal-article","created":{"date-parts":[[2014,11,11]],"date-time":"2014-11-11T23:24:26Z","timestamp":1415748266000},"page":"221-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Infecciones graves en pacientes con enfermedades autoinmunes tratados con ciclofosfamida"],"prefix":"10.1016","volume":"11","author":[{"given":"Javier A.","family":"Cavallasca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia A.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria del Rosario","family":"Maliandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana E.","family":"Contini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Fernandez de Carrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge L.","family":"Musuruana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reuma.2014.09.003_bib0005","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0889-857X(02)00100-X","article-title":"Infections in systemic connective tissue diseases: Systemic lupus erythematosus, scleroderma, and polymyositis\/dermatomyositis","volume":"29","author":"Ju\u00e1rez","year":"2003","journal-title":"Rheum Dis Clin North Am."},{"key":"10.1016\/j.reuma.2014.09.003_bib0010","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.mcna.2012.04.003","article-title":"Immunotherapies in rheumatologic disorders","volume":"96","author":"Miller","year":"2012","journal-title":"Med Clin North Am."},{"key":"10.1016\/j.reuma.2014.09.003_bib0015","series-title":"Practical statistics for medical research","author":"Altman","year":"1991"},{"key":"10.1016\/j.reuma.2014.09.003_bib0020","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7326\/0003-4819-98-1-76","article-title":"Wegener's granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years","volume":"98","author":"Fauci","year":"1983","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.reuma.2014.09.003_bib0025","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJM198603063141004","article-title":"Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs","volume":"314","author":"Austin","year":"1986","journal-title":"N Engl J Med."},{"key":"10.1016\/j.reuma.2014.09.003_bib0030","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/096120339700600307","article-title":"Side-effects of intravenous cyclophosphamide pulse therapy","volume":"6","author":"Martin","year":"1997","journal-title":"Lupus."},{"key":"10.1016\/j.reuma.2014.09.003_bib0035","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/ard.51.7.885","article-title":"Short term effects of intravenous pulses of cyclophosphamide in the treatment of connective tissue disease crisis","volume":"51","author":"Haga","year":"1992","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2014.09.003_bib0040","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/ard.56.8.481","article-title":"Immunosuppressive treatment in severe connective tissue diseases: Effects of low dose intravenous cyclophosphamide","volume":"56","author":"Martin-Suarez","year":"1997","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2014.09.003_bib0045","series-title":"Kelley's textbook of rheumatology","first-page":"879","article-title":"Immunoregulatory drugs","author":"Stein","year":"2001"},{"key":"10.1016\/j.reuma.2014.09.003_bib0050","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/art.1780390906","article-title":"Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus","volume":"39","author":"Pryor","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reuma.2014.09.003_bib0055","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2165\/00002018-200730100-00005","article-title":"Corticosteroid-induced adverse events in adults: frequency, screening and prevention","volume":"30","author":"Fardet","year":"2007","journal-title":"Drug Saf."}],"container-title":["Reumatolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X14002009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X14002009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T21:20:11Z","timestamp":1538083211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1699258X14002009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1699258X14002009"],"URL":"https:\/\/doi.org\/10.1016\/j.reuma.2014.09.003","relation":{},"ISSN":["1699-258X"],"issn-type":[{"value":"1699-258X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infecciones graves en pacientes con enfermedades autoinmunes tratados con ciclofosfamida","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2014.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}